MedTrace Logo

Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)

NCT00638300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2010-07-13

No results posted yet for this study

Summary

The study's hypothesis is that HD with large pore dialyzers remove to the dialysate iron which is bound to potentially dialyzable ligands, after it's release from intravenous iron compound administered during hemodialysis.

Conditions

  • Hemodialysis Patients

Interventions

DEVICE

large pore (FX80) compared to small pore dialyzer (F8HPS)

Effect of pore size

OTHER

Dialysate bicarbonate of 33 mEq/L compared to 40 mEq/L

Effect of dialysate bicarbonate concentration

OTHER

Dialysate calcium of 3 mEq/L compared to 2.5 mEq/L

Effect of dialysate calcium concentration

Sponsors & Collaborators

  • Bnai Zion Medical Center

    collaborator OTHER_GOV

  • Rivka Ziv Medical Center

    collaborator UNKNOWN

  • Soroka University Medical Center

    lead OTHER

Principal Investigators

  • David Tovbin, MD · Soroka University Medical Center

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
88 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2009-12-31
Completion
2010-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00638300 on ClinicalTrials.gov